Suppr
超能文献

Changing epidemiology of hepatocellular cancer in the United States: Winning the battle but it is not over yet.

作者信息

Khaderi Saira, Kanwal Fasiha

机构信息

Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.

Section of Health Services Research, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.

出版信息

Hepatology. 2022 Sep;76(3):546-548. doi: 10.1002/hep.32512. Epub 2022 Apr 22.

DOI:10.1002/hep.32512

PMID:35388520

Abstract

摘要

相似文献

Changing epidemiology of hepatocellular cancer in the United States: Winning the battle but it is not over yet.

Hepatology. 2022 Sep;76(3):546-548. doi: 10.1002/hep.32512. Epub 2022 Apr 22.

Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go?

Hepatology. 2014 Nov;60(5):1767-75. doi: 10.1002/hep.27222. Epub 2014 Aug 25.

Hepatocellular carcinoma in HIV-infected patients comes of age: The convergence of epidemiology and treatment effectiveness.

J Hepatol. 2009 Apr;50(4):655-8. doi: 10.1016/j.jhep.2009.01.009. Epub 2009 Feb 11.

Hepatocellular carcinoma in the United States. Lessons from a population-based study in Medicare recipients.

J Hepatol. 2006 Jan;44(1):8-10. doi: 10.1016/j.jhep.2005.11.001. Epub 2005 Nov 8.

Recent Decline in Hepatocellular Carcinoma Rates in the United States.

Gastroenterology. 2020 Apr;158(5):1503-1505.e2. doi: 10.1053/j.gastro.2019.12.030. Epub 2020 Jan 19.

Liver cancer on the rise.

Ann Intern Med. 2005 Jun 21;142(12 Pt 1):1029-32. doi: 10.7326/0003-4819-142-12_part_1-200506210-00024.

The increasing incidence of hepatocellular carcinoma.

N Engl J Med. 1999 Mar 11;340(10):798-9. doi: 10.1056/NEJM199903113401009.

Diabetes and hepatocellular carcinoma: associations, biologic plausibility, and clinical implications.

Gastroenterology. 2005 Sep;129(3):1132-4. doi: 10.1053/j.gastro.2005.06.079.

Surveillance for hepatocellular carcinoma.

Ann Intern Med. 2011 Aug 16;155(4):274-5; author reply 275. doi: 10.7326/0003-4819-155-4-201108160-00017.

Surveillance for hepatocellular carcinoma.

Ann Intern Med. 2011 Aug 16;155(4):274; author reply 275. doi: 10.7326/0003-4819-155-4-201108160-00016.

引用本文的文献

Risk Stratification Model for Hepatocellular Cancer in Patients With Cirrhosis.

Clin Gastroenterol Hepatol. 2023 Dec;21(13):3296-3304.e3. doi: 10.1016/j.cgh.2023.04.019. Epub 2023 Apr 30.

Radiological-histopathological discordance in patients transplanted for HCC and its impact on post-transplant outcomes.

Cancer Med. 2023 Jul;12(14):15011-15025. doi: 10.1002/cam4.6161. Epub 2023 Jun 16.

Emerging Role of Cancer-Associated Fibroblasts in Progression and Treatment of Hepatocellular Carcinoma.

Int J Mol Sci. 2023 Feb 15;24(4):3941. doi: 10.3390/ijms24043941.

What to do about hepatocellular carcinoma: Recommendations for health authorities from the International Liver Cancer Association.

JHEP Rep. 2022 Sep 8;4(12):100578. doi: 10.1016/j.jhepr.2022.100578. eCollection 2022 Dec.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Changing epidemiology of hepatocellular cancer in the United States: Winning the battle but it is not over yet.

Hepatology. 2022 Sep;76(3):546-548. doi: 10.1002/hep.32512. Epub 2022 Apr 22.

Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go?

Hepatology. 2014 Nov;60(5):1767-75. doi: 10.1002/hep.27222. Epub 2014 Aug 25.

Hepatocellular carcinoma in HIV-infected patients comes of age: The convergence of epidemiology and treatment effectiveness.

J Hepatol. 2009 Apr;50(4):655-8. doi: 10.1016/j.jhep.2009.01.009. Epub 2009 Feb 11.

Hepatocellular carcinoma in the United States. Lessons from a population-based study in Medicare recipients.

J Hepatol. 2006 Jan;44(1):8-10. doi: 10.1016/j.jhep.2005.11.001. Epub 2005 Nov 8.

Recent Decline in Hepatocellular Carcinoma Rates in the United States.

Gastroenterology. 2020 Apr;158(5):1503-1505.e2. doi: 10.1053/j.gastro.2019.12.030. Epub 2020 Jan 19.

Liver cancer on the rise.

Ann Intern Med. 2005 Jun 21;142(12 Pt 1):1029-32. doi: 10.7326/0003-4819-142-12_part_1-200506210-00024.

The increasing incidence of hepatocellular carcinoma.

N Engl J Med. 1999 Mar 11;340(10):798-9. doi: 10.1056/NEJM199903113401009.

Diabetes and hepatocellular carcinoma: associations, biologic plausibility, and clinical implications.

Gastroenterology. 2005 Sep;129(3):1132-4. doi: 10.1053/j.gastro.2005.06.079.

Surveillance for hepatocellular carcinoma.

Ann Intern Med. 2011 Aug 16;155(4):274-5; author reply 275. doi: 10.7326/0003-4819-155-4-201108160-00017.

Surveillance for hepatocellular carcinoma.

Ann Intern Med. 2011 Aug 16;155(4):274; author reply 275. doi: 10.7326/0003-4819-155-4-201108160-00016.

引用本文的文献

Risk Stratification Model for Hepatocellular Cancer in Patients With Cirrhosis.

Clin Gastroenterol Hepatol. 2023 Dec;21(13):3296-3304.e3. doi: 10.1016/j.cgh.2023.04.019. Epub 2023 Apr 30.

Radiological-histopathological discordance in patients transplanted for HCC and its impact on post-transplant outcomes.

Cancer Med. 2023 Jul;12(14):15011-15025. doi: 10.1002/cam4.6161. Epub 2023 Jun 16.

Emerging Role of Cancer-Associated Fibroblasts in Progression and Treatment of Hepatocellular Carcinoma.

Int J Mol Sci. 2023 Feb 15;24(4):3941. doi: 10.3390/ijms24043941.

What to do about hepatocellular carcinoma: Recommendations for health authorities from the International Liver Cancer Association.

JHEP Rep. 2022 Sep 8;4(12):100578. doi: 10.1016/j.jhepr.2022.100578. eCollection 2022 Dec.

Suppr超能文献

Changing epidemiology of hepatocellular cancer in the United States: Winning the battle but it is not over yet.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译